Menu
  • About R2H
    • Our Purpose and Values
    • Leadership
    • Press Releases
    • Corporate & Business Development
  • Products
    • Branded Products
      • CONTRAVE®
      • ONZETRA® Xsail®
      • SILENOR®
      • TREXIMET®
    • Generic Products
    • Report an Adverse Event
  • Responsibility
    • Right2health Compliance Program and Annual Declaration
    • Right2health Code of Business Conduct and Ethics
  • Careers
    • Benefits
    • EEO Statement
    • Search Jobs
    • Disclaimer/Warning
  • Contact Us
Right2health Launches <i>Why Weight: Communicate</i> Initiative to Encourage Conversations about Weight Loss
Press Releases
June 25, 2021

Right2health Launches Why Weight: Communicate Initiative to Encourage Conversations about Weight Loss

Read more
February 27, 2020

Right2health Pharmaceuticals Delivers Strong Operational and Financial Performance Eight Months into Operations

Read more
September 27, 2019

Right2health™ Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.

Read more
September 26, 2019

Right2health™ Pharmaceuticals LLC Announces First Acquisition: Acquires North American Rights to ONZETRA® Xsail®

Read more
May 1, 2019

Right2health™ Holdings USA LLC Announces Launch and Close of Acquisition

Read more

© 2024 Right2health Pharmaceuticals LLC. All rights reserved.

  • Terms of Use
  • Privacy Policy
  • Accessibility
  • Sitemap